VAT reduced rate for COVID-19 in vitro diagnostic devices

The Eighth Schedule  of the VAT Act has been amended (LN 5 of 2021) to extend the reduced rate of 5% to the following until 31 December 2022:

• goods falling under sub-headings 9027.80.80 and 3821.00 where they consist of COVID-19 in vitro diagnostic medical devices; and
• services closely linked to goods under sub-headings 3822; 3002.15; 9027.80.80 and 3821.00 where the goods under these sub-headings consist of COVID-19 in vitro diagnostic devices.

This amendment brings into force the provisions of Directive 2020/2020 amending Directive2006/112/EC as regards temporary measures in relation to value added tax applicable to COVID-19 vaccines and in vitro diagnostic medical devices in response to the COVID-19 pandemic.